Alcon AG reported $964M in Selling and Administration Expenses for its fiscal quarter ending in June of 2026.





Selling And Administration Expenses Change Date
AstraZeneca USD 4.07B 1.73B Sep/2026
Bayer EUR 4.02B 53M Sep/2026
Essilor EUR 5.75B 139M Jun/2026
Fresenius EUR 823M 63M Sep/2026
Fresenius Medical Care EUR 744M 7.99M Sep/2026
GlaxoSmithKline GBP 2.16B 39M Sep/2026
GRIFOLS EUR 326M 37M Sep/2026
Merck EUR 1.58B 11M Sep/2026
Novartis USD 3.08B 163M Sep/2026
Philips EUR 1.17B 33M Sep/2026
Roche Holding CHF 6.37B 908M Jun/2026
Sanofi EUR 2.31B 325M Sep/2026
Smith & Nephew USD 1.45B 29M Jun/2026
Sonova Holding CHF 880.2M 300K Jun/2025
UCB EUR 1.47B 193M Dec/2025